02-11-2026 23:32 via MedPageToday.com - medical news for physicians

Late-Stage Sickle Cell Disease Study Splits on Main Goals

(MedPage Today) -- The thalassemia drug mitapivat (Aqvesme) significantly improved hemoglobin response in patients with sickle cell disease but failed to top placebo when it came to reducing pain crises in a phase III trial that aims to support...
Read more »

Medical Industry news



Brain Injury Creates Musical Genius; Long COVID Improvement; Dementia and Delirium
Cool Temps and HF; Death After On-Field Collision; Shave and Shake in Stenting
What Will the Midterms Mean for Healthcare?
De-Escalated Treatment for HPV-Related Throat Cancer Gets Long-Term Supporting Data
Pinch Hitting for the Geriatricians
Generic Lenacapavir Approval for HIV Prevention Raises Hope in Low-Income Nations
Voting and Premature Death; Doctors on the Ballot; 'Three-Parent' IVF Tourism
Child Dies of Measles in New York's First Such Death in 30 Years
Their Names Sound Like Legacy Medical Groups. Their Agendas Tell a Different Story.
Novel Therapy Lands Speedy Approval for Wart-Like Airway Disease
Study Strengthens Case for Stent-Free PCI in De Novo Coronary Lesions
Washington State Resident Dies From Bird Flu Following Exposure to Infected Cattle
CTE in NFL Players: What a New Study Tells Us -- And What It Doesn't
Parents' Autoimmune Disease Linked to Kids' Type 1 Diabetes Risk
Desktop versie